Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease malignant glioma
Phenotype C0011334|cavities
Sentences 1
PubMedID- 22144871 Zalutsky et al[44] investigated the use of 211at-labeled chimeric 81c6 antitenascin monoclonal antibodies administered to surgically created (tumor) resection cavities in patients with recurrent malignant gliomas.

Page: 1